Showing results (1131-1140 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|February 6, 1999
A risk-benefit assessment of abciximab in angioplastyN S Kleiman
Drug Safety|February 6, 1999
Inhaled corticosteroids and cataract: prevalence, prevention and managementR G Cumming, P Mitchell
Drug Safety|January 8, 1999
Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?T M Karplus, K G Saag
Drug Safety|January 8, 1999
Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacologyA Nordberg, A L Svensson
Drug Safety|January 8, 1999
Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significanceP Loiseau
Drug Safety|December 22, 2007
Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registriesRachel A Charlton, Marianne C Cunnington, Corinne S de Vries, et al.
Drug Safety|May 20, 2008
Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribersYu Ko, Daniel C Malone, Grant H Skrepnek, et al.
Drug Safety|February 6, 2025
A Longitudinal Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: A Cohort Study in Denmark and Sweden, 2013-2021Annette Kjær Ersbøll, Zhiping Huang, Deanna D Hill, et al.
Drug Safety|February 5, 2025
Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTIONJonathan L Richardson, Alan Moore, Michael Stellfeld, et al.
Drug Safety|January 20, 2025
Clinical Relatedness and Stability of vigiVec Semantic Vector Representations of Adverse Events and Drugs in PharmacovigilanceNils Erlanson, Joana Félix China, Henric Taavola, et al.
Pageof 311